OncoTherapy Science, Inc. transfers its own Tumor Immunology department, which has been conducting development of cancer immunotherapies and TCR/BCR repertoire analysis to Cancer Precision Medicine, Inc.. We will work with a renewed resolve in this newly established company, CPM.